Saku App
Saku Terminal • $PFELive $PFE AI Target, Catalysts & Support Levels
OPEN
Saku Logo
Saku
Back to Saku Market Terminal
Climate: SUNNY
Updated Nov 22, 2026
Saku AI Market Briefing • $PFE (Pfizer Inc.)

$PFE (Pfizer Inc.) Support & Resistance Levels, AI Price Target & Institutional Flow.

Today, $PFE (Pfizer Inc.) trades at $27.45 (-0.51%) with a 85/100 Momentum Pulse (SUNNY) and 14D RSI at 21.4 (OVERSOLD VALUE (21.4)). Unlock the live $PFE support and resistance levels, 30D Put Wall floor, 20D SMA pivot, Call Wall ceiling, dark pool flow, and locked 1-Month AI Price Target (+14.2% upside corridor) below—or create a free 24/7 AI quant agent to guard $PFE.

Saku AI Synthesis • Why Is $PFE Moving?
30D Support$27.40
30D Resistance$30.35
20-Day SMA$29.12
14-Day RSI21.4

Pfizer (PFE) stock is moving up today after reporting better-than-expected second-quarter 2026 earnings, raising its full-year revenue guidance midpoint due to strong non-COVID product sales, which offset declines in COVID-19 related products.

LIVE TERMINAL TELEMETRY
$27.45-0.51%
BULLISH FLOW
$PFE 30-DAY PRICE ACTION • SUNNYUpdated Nov 22, 2026
$PFE Momentum Pulse (1–100)85/100
Fundamental Health Score70/100
Assign Ronin to Guard $PFE 24/7
3x/Day Shift Briefs & 24/7 Stop-Loss Sentinel
+ GUARD
Locked 1-Month AI Target:$31.35 (+14.2%)Unlock Free →
Open Interactive $PFE Chart & Ask @Saku
Institutional Quantitative & Fundamental Telemetry

$PFE (Pfizer Inc.) Live Key Levels, RSI & Valuation Matrix

Updated Nov 22, 2026
$PFE Technical MetricLive Value$PFE Fundamental / Regime MetricLive Status
Live Spot Price (24h Change)$27.45 (-0.51%)Market Capitalization$156.17B
30-Day Mechanical Support Floor (Put Wall)$27.40 (0.18% cushion)52-Week High / Low Range$23.62 – $31.44
20-Day Simple Moving Average (20D SMA)$29.12Trailing P/E Ratio & Dividend Yield38.72x • Yield: 6.28%
10-Day Exponential Moving Average (10D EMA)$28.37Average Daily Volume (Liquidity)40.45M shares
30-Day Resistance Ceiling (Call Wall)$30.35 (10.55% upside to test)Next Scheduled Earnings / Catalyst Window2026-11-03
14-Day Relative Strength Index (RSI)OVERSOLD VALUE (21.4)Saku Momentum Pulse & Health Rating85/100 Momentum • 70/100 Health
Want live sub-second candlesticks, 20D SMA / 50D EMA overlays, and real-time Support & Resistance alerts on $PFE?Launch Interactive $PFE Chart
Saku AI Bull vs. Bear Breakdown

Should You Buy $PFE Stock Now or Wait?

$PFE Bull CaseUPSIDE DRIVERS

Pfizer's robust performance in its non-COVID product portfolio, enhanced revenue guidance, and ongoing productivity initiatives suggest a resilient business poised for sustained growth.

Momentum Pulse: 85/100 (SUNNY)Predict Bull Target
$PFE Bear Case & RisksRISK FACTORS

Declining COVID-19 product revenues and a notable pipeline setback in oncology highlight potential challenges in future growth and the need for successful new drug development.

Fundamental Health: 70/100 ScoreAudit Downside Risk
Technicals, Volume & Catalysts

$PFE Support & Resistance, Institutional Flow & Catalysts.

Key Price Zones

$PFE Support & Resistance

Spot Price: $27.45 | 30-Day Support Floor: $27.40 (0.18% above) | 10-Day EMA: $28.37 | 20-Day SMA Pivot: $29.12 | 30-Day Resistance Ceiling: $30.35 (10.55% below) | 14-Day RSI: 21.4 (OVERSOLD VALUE (21.4)) | 30-Day Trading Corridor: 10.75% span. AI Desk Note: Immediate support for PFE stock is at $24.80, with resistance at $25.33.

Chart IndicatorsSMA • EMA • RSI
Volume & Options Activity

$PFE Institutional & Whale Flow

Increased institutional interest is likely as positive earnings and raised guidance typically attract large-scale investors.

Saku Pro Deep-DiveTRACKED
Upcoming Events

$PFE Catalyst Outlook

Upcoming key pivotal readouts from its late-stage pipeline are expected over the next 12 months, with a PDUFA action date for Talzenna in Q4 2026.

Asset & Corporate Profile

About Pfizer Inc. ($PFE)

Seagen and Astellas previously entered a clinical collaboration agreement with MSD to evaluate the combination of Seagen's and Astellas' PADCEV TM (enfortumab vedotin) and MSD's KEYTRUDA ® (pembrolizumab) in patients with urothelial cancer. Pfizer Inc. successfully completed its acquisition of Seagen on December 14, 2023. KEYTRUDA is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada). About XTANDI and the Pfizer/Astellas Collaboration In October 2009, Medivation, Inc., which is now part of Pfizer, and Astellas (TSE: 4503) entered into a commercial agreement to jointly develop and commercialize XTANDI ® (enzalutamide) in the United States, while Astellas has responsibility for manufacturing and all additional regulatory filings globally, as well as commercializing the product outside the United States.

Saku's quantitative engine continuously monitors $PFE's 30-day mechanical support floor ($27.40), 20-day simple moving average ($29.12), and 30-day resistance ceiling ($30.35) alongside off-exchange dark pool block prints and SEC filings.

Market Cap$156.17B
5-Day Velocity-5.16%
52-Week Range$23.62 – $31.44
Avg Daily Vol40.45M shares
Inspect Full $PFE Fundamentals in Terminal
3D Agent Sanctuary • Workstation #4🔥 Early Adopter Lock-In (First 500 Desks)🎁 Code LINKEDIN: 30 Days Pro Free

Hatch Your Own 24/7 AI Co-Pilot to Guard $PFE.

Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $PFE 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

Unlock all 4 Autonomous Quant Agents & 24/7 Stop-Loss Guard:$29/mo$14.99/mo(or $8.33/mo annual • Early Adopter Rate + 30 Days Free w/ code LINKEDIN)
app.sakustocks.com • Live $PFE Terminal & Agent Sanctuary
Launch Full Terminal
Saku Institutional AI Terminal analyzing $PFE (Pfizer Inc.)
“Ask @Saku or Ronin: Would you buy $PFE right now or wait for a pullback?”
5 Guard Slots • 50 Daily @Saku Queries
Frequently Asked Questions About $PFE

What are the live 30-day support and resistance levels for $PFE (Pfizer Inc.)?

Spot Price: $27.45 | 30-Day Support Floor: $27.40 (0.18% above) | 10-Day EMA: $28.37 | 20-Day SMA Pivot: $29.12 | 30-Day Resistance Ceiling: $30.35 (10.55% below) | 14-Day RSI: 21.4 (OVERSOLD VALUE (21.4)) | 30-Day Trading Corridor: 10.75% span. AI Desk Note: Immediate support for PFE stock is at $24.80, with resistance at $25.33. $PFE currently registers a Saku Momentum Pulse score of 85/100 and a Fundamental Health score of 70/100.

Why is $PFE (Pfizer Inc.) moving and what is the bull vs. bear thesis?

Bull Thesis: Pfizer's robust performance in its non-COVID product portfolio, enhanced revenue guidance, and ongoing productivity initiatives suggest a resilient business poised for sustained growth. Bear Thesis: Declining COVID-19 product revenues and a notable pipeline setback in oncology highlight potential challenges in future growth and the need for successful new drug development.

What are $PFE's key fundamentals, 52-week range, and upcoming catalysts?

Pfizer Inc. ($PFE) trades with a market cap of $156.17B, a P/E ratio of 38.72x, and a 52-week range of $23.62 to $31.44. Upcoming key pivotal readouts from its late-stage pipeline are expected over the next 12 months, with a PDUFA action date for Talzenna in Q4 2026.

Saku Tracked Assets

Explore More AI Stock & Crypto Quant Dossiers

View 14-Day Catalyst Calendar →

© 2026 Saku Financial Inc. Saku™ is a trademark of Saku Financial Inc.